新型冠状病毒肺炎感染中的血栓栓塞性疾病。

Thromboembolic Disorder in COVID-19 Infection.

机构信息

Department of Cardiovascular Diseases, Mount Sinai St. Luke's Icahn School of Medicine, 1111 Amsterdam Ave, New York, NY 10025, USA.

School of Medicine, University of Arizona College of Medicine, 1501 N Campbell Ave, Tucson, AZ 85724, USA.

出版信息

Curr Med Imaging. 2023;19(14):1616-1627. doi: 10.2174/1573405619666230216112751.

DOI:10.2174/1573405619666230216112751

PMID:36797601

Abstract

Coronavirus (COVID-19) is a global pandemic with over 600 million cases identified. In addition to extensive pulmonary complications of COVID-19, one feature unique to many patients with severe COVID-19 infections is coagulopathy with a rising prevalence of multi-systemic thromboembolic manifestations. Global data suggests a relationship between coagulopathy and mortality. In this review, we highlight multiple COVID-19 thromboembolic complications with emphasis on pathophysiology, clinical management, and radiological manifestations.

摘要

冠状病毒（COVID-19）是一种具有全球影响的大流行病，已确诊病例超过 6 亿例。除了 COVID-19 的广泛肺部并发症外，许多重症 COVID-19 感染患者的一个独特特征是凝血功能障碍，多系统血栓栓塞表现的患病率不断上升。全球数据表明凝血功能障碍与死亡率之间存在关联。在这篇综述中，我们重点介绍了 COVID-19 的多种血栓栓塞并发症，强调了其病理生理学、临床管理和影像学表现。